Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets
V. Jayalakshmi, Albin John, Willayat Yousuf Wani, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165889-165889
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Coronavirus envelope protein: current knowledge
Dewald Schoeman, Burtram C. Fielding
Virology Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 2081
Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
Jaegyun Lim, Seunghyun Jeon, Hyun‐Young Shin, et al.
Journal of Korean Medical Science (2020) Vol. 35, Iss. 6
Open Access | Times Cited: 657
Long-Term Respiratory and Neurological Sequelae of COVID-19
Fuzhou Wang, Richard M. Kream, George B. Stefano
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 414
Sudden irreversible hearing loss post COVID-19
Foteini Koumpa, Cillian T. Forde, Joseph Manjaly
BMJ Case Reports (2020) Vol. 13, Iss. 11, pp. e238419-e238419
Open Access | Times Cited: 210
The chronic neuropsychiatric sequelae of COVID‐19: The need for a prospective study of viral impact on brain functioning
Gabriel A. de Erausquin, Heather M. Snyder, María C. Carrillo, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 6, pp. 1056-1065
Open Access | Times Cited: 183
A comprehensive review of the impact of COVID-19 on human reproductive biology, assisted reproduction care and pregnancy: a Canadian perspective
Mitko Madjunkov, Michal Dviri, Clifford Librach
Journal of Ovarian Research (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 173
FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Sylwester Drożdżal, Jakub Rosik, Kacper Lechowicz, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100719-100719
Open Access | Times Cited: 170
The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID‐19
Hao Tang, Yuehan Gao, Zhaohuai Li, et al.
Clinical and Translational Medicine (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 136
Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases
Riya Ganji, P. Hemachandra Reddy
Frontiers in Aging Neuroscience (2021) Vol. 12
Open Access | Times Cited: 95
Computational repurposing of tamibarotene against triple mutant variant of SARS-CoV-2
Somdutt Mujwar
Computers in Biology and Medicine (2021) Vol. 136, pp. 104748-104748
Open Access | Times Cited: 61
SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer’s-like neuropathology
Wei‐Bin Shen, Montasir Elahi, James Logue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 57
<p>Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database</p>
Rimple Jeet Kaur, Jaykaran Charan, Siddhartha Dutta, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 4427-4438
Open Access | Times Cited: 64
The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia
Katherine Holder, P. Hemachandra Reddy
The Neuroscientist (2020) Vol. 27, Iss. 4, pp. 331-339
Open Access | Times Cited: 50
Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111330-111330
Open Access | Times Cited: 46
SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients
Francisco Alves de Sousa, Rodrigo Pinto Costa, Sandra Xará, et al.
Journal of Otology (2021) Vol. 16, Iss. 3, pp. 158-164
Open Access | Times Cited: 32
SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
Peyman Kheirandish Zarandi, Mohammad Reza Zinatizadeh, Maryam Zinatizadeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111352-111352
Open Access | Times Cited: 31
Sudden Sensorineural Hearing Loss in the COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Andrea Frosolini, Leonardo Franz, Antonio Daloiso, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3139-3139
Open Access | Times Cited: 20
A Comparative NLP-Based Study on the Current Trends and Future Directions in COVID-19 Research
Priyankar Bose, Satyaki Roy, Preetam Ghosh
IEEE Access (2021) Vol. 9, pp. 78341-78355
Open Access | Times Cited: 24
Repurposing FDA-approved Drugs Targeting SARS-CoV2 3CLpro: A Study by Applying Virtual Screening, Molecular Dynamics, MM-PBSA Calculations and Covalent Docking
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 7, pp. 637-653
Closed Access | Times Cited: 16
Identification of B-Cell Epitopes for Eliciting Neutralizing Antibodies against the SARS-CoV-2 Spike Protein through Bioinformatics and Monoclonal Antibody Targeting
Hui Xuan Lim, Malihe Masomian, Kanwal Khalid, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4341-4341
Open Access | Times Cited: 16
TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2
Lanying Li, Ying-Zhe Fan, Yitong Huang, et al.
Cellular Signalling (2021) Vol. 85, pp. 110064-110064
Open Access | Times Cited: 22
Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-2
Kyoung Bo Kim, Hayoung Choi, Dong‐Gun Lee, et al.
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 5, pp. 617-628
Open Access | Times Cited: 22
Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach
Sajad Fakhri, Sana Piri, Mohammad Bagher Majnooni, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 21
Virus blocking textile for SARS-CoV-2 using human body triboelectric energy harvesting
Minki Kang, Na-Yoon Jang, Young‐Jun Kim, et al.
Cell Reports Physical Science (2022) Vol. 3, Iss. 4, pp. 100813-100813
Open Access | Times Cited: 15
Research Progress on the Role of Microglia Membrane Proteins or Receptors in Neuroinflammation and Degeneration
Junfeng Zhao, Tong Ren, Xiangyu Li, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top